Validation of an Urticaria Control Test

The aim of this study is to validate a previously developed patient reported outcome instrument (in project UCT-D) to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Urticaria Chronic Disease Disease Attributes Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Skin Diseases Skin Diseases, Vascular Skin and Connective Tissue Diseases Urticaria

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitätshautklinik Mainz, Mainz, Rhineland-Palatinate, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

all patients suffering from chronic forms of urticaria are eligible

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Official study title

Development (and Validation) of an Instrument to Assess Disease Control in Patients With Urticaria (Urticaria Control Test)

Acronym: UCT-V

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Jun 8, 2012
Registry last updated: Jan 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed